UK MHRA issues new guidance for medtech and IVD companies in wake of Brexit

By Ronald Boumans, Emergo Group

In early August 2018 the UK Medicines & Healthcare products Regulatory Agency (MHRA) issues three new guidance documents for medical device, IVD and related healthcare sectors to prepare for ramifications of Brexit.

Get the full story here at the Emergo Group’s blog.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

The post UK MHRA issues new guidance for medtech and IVD companies in wake of Brexit appeared first on MassDevice.

from MassDevice https://ift.tt/2NszcG8